- Report
- January 2025
- 134 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 140 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- March 2025
- 250 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- November 2024
- 157 Pages
Global
From €3640EUR$4,000USD£3,121GBP
- Report
- November 2021
- 144 Pages
Global
From €3640EUR$4,000USD£3,121GBP
- Report
- August 2024
- 92 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2022
- 270 Pages
Global
From €3378EUR$3,712USD£2,896GBP
Interbody fusion cages are orthopedic devices used to treat spinal disorders such as degenerative disc disease, spondylolisthesis, and spinal instability. The device is inserted between two vertebrae to provide stability and support while the vertebrae fuse together. The cage is typically made of titanium or a titanium alloy and is designed to be porous to allow for bone growth. It is often filled with bone graft material to promote fusion.
Interbody fusion cages are used in a variety of spinal surgeries, including anterior lumbar interbody fusion (ALIF), posterior lumbar interbody fusion (PLIF), and transforaminal lumbar interbody fusion (TLIF). The cages are designed to provide stability and support while allowing for the fusion of the vertebrae.
The interbody fusion cage market is a growing segment of the orthopedic device industry. The increasing prevalence of spinal disorders and the growing demand for minimally invasive surgical procedures are driving the growth of the market.
Some of the major companies in the interbody fusion cage market include Medtronic, Stryker, Zimmer Biomet, DePuy Synthes, and NuVasive. Show Less Read more